Andere talen ProstaLund AB

Aandelen

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:29:31 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,12 ^SEK	+2,75%		+14,52%	-31,29%

08/04	ProstaLund AB (Publ) presenteert twee nieuwe onderzoeken met Schelin Catheter	CI
16/02	ProstaLund AB (publ) rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 december 2023	CI

ProstaLund hosted unannounced audit by TÜV SÜD	12/04
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris	08/04
ProstaLund AB Presents Two New Studies with Schelin Catheter	08/04
Schelin Catheter® - new study confirms efficiency and ease of use	27/02
Year-end report – ProstaLund AB (publ)	16/02
ProstaLund AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
New agreement - Esbjerg Hospital starts up with CoreTherm® treatments	12/12
ProstaLund Signs an Agreement on Coretherm®? with the New Customer Sydvestjysk Sygehus	12/12
Interim report - ProstaLund AB (publ)	07/11
ProstaLund AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Schelin Catheter® has had its premiere in France.	11-09-23
ProstaLund AB Announces its Schelin Catheter Premiere in France	11-09-23
Schelin Catheter® beneficial together with TURP	05-09-23
ProstaLund signs sales agent agreement for France	31-08-23
Prostalund Signs Sales Agent Agreement for France	31-08-23
Patent has been approved in China	15-08-23
ProstaLund AB Receives the Positive News on Utility Model Application for Their Product CoreFlow Soft Stent	15-08-23
ProstaLund AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25-07-23
Very strong sales in the quarter, + 53 %	14-07-23
ProstaLund to File De Novo Application in US for Catheter Product	11-07-23

Geen resultaten voor deze zoekopdracht